Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Takeda
Takeda
Takeda’s Vedolizumab Clears Phase III in aGvHD
BioSpace
Tue, 02/21/23 - 10:03 am
Takeda
vedolizumab
graft vs host disease
clinical trials
Takeda's Iclusig shows potential to become standard of care in acute lymphoblastic leukemia subtype
Fierce Pharma
Wed, 02/15/23 - 06:16 pm
Takeda
Iclusig
acute lymphoblastic leukemia
ALL
ASCO
Japan cancels 140M dose order for Novavax Covid vaccine amid 'lower than expected' demand
Endpoints
Sun, 02/12/23 - 07:44 pm
Japan
Novavax
COVID-19
vaccines
Takeda
Takeda focuses on ‘diverse’ pipeline prospects on heels of two acquisitions
Endpoints
Mon, 02/6/23 - 10:55 am
Takeda
Nimbus Therapeutics
Hutchmed
colorectal cancer
psoriasis
fruquintinib
Q4 earnings roundup: Merck, Lilly, Takeda and BMS release financials
Medical Marketing and Media
Thu, 02/2/23 - 10:55 am
earnings
Merck
Takeda
Bristol Myers Squibb
Eli Lilly
The world's twelfth VEGF drug will be sold by Takeda
EP Vantage
Mon, 01/23/23 - 10:43 am
Takeda
Hutchmed
VEGF
fruquintinib
Biopharma's stock market winners of 2022 revealed
EP Vantage
Wed, 01/18/23 - 09:46 am
pharma stocks
Merck
Eli Lilly
AbbVie
Daiichi Sankyo
Vertex Pharmaceuticals
Takeda
Sarepta Therapeutics
Halozyme
Horizon Therapeutics
Boehringer, Takeda make it into global top 15 employer list
Pharmaphorum
Tue, 01/17/23 - 10:25 am
Boehringer Ingelheim
Takeda
Top Employers
Ex-Takeda staffer's 'small hustle' ends with arrest and $2.3M fraud scheme charge
Endpoints
Mon, 01/16/23 - 11:10 am
Takeda
fraud
legal
JPM23: Takeda tests Bristol Myers, Prime weighs spinoffs and Sanofi faces down a competitor
BioPharma Dive
Wed, 01/11/23 - 11:08 pm
JPMHC 2023
Takeda
Bristol Myers Squibb
Prime Medicine
Sanofi
JPM23, Day 3: Takeda relishing in-person meetups
Fierce Biotech
Wed, 01/11/23 - 10:55 am
JPMHC 2023
Takeda
JPM23, Day 2: Takeda readies for dengue vaccine launch; Merck touts recent deals
Fierce Pharma
Tue, 01/10/23 - 10:50 am
JPMHC 2023
Takeda
vaccines
Roche
GSK
Bayer
Merck
Takeda touts interim PhIII data of enzyme replacement therapy for rare blood disease
Endpoints
Thu, 01/5/23 - 04:44 pm
Takeda
clinical trials
cTTP
cogenital thrombocytopenic purpura
FDA decision, launch of gastrointestinal drug delayed after nitrosamine found in commercial batches
Endpoints
Wed, 01/4/23 - 10:03 am
Phathom Pharmaceuticals
Takeda
nitrosamine
vonoprazan
FDA
erosive esophagitis
10 clinical trials to watch in the first half of 2023
BioPharma Dive
Tue, 01/3/23 - 10:57 am
clinical trials
Alzheimer's disease
obesity
Huntington's disease
M&A
AstraZeneca
Daiichi Sankyo
Nimbus Therapeutics
Takeda
Eli Lilly
Sanofi
Regeneron
Moderna Therapeutics
Gilead Sciences
Pfizer
Roivant
Alnylam
uniQure
Takeda wagers up to $6B on Nimbus’ TYK2 drug
BioPharma Dive
Tue, 12/13/22 - 10:43 am
Takeda
Nimbus Therapeutics
autoimmune diseases
NDI-034858
GSK, Sanofi, Takeda sign with Singapore partnership to advance biologic manufacturing
Fierce Pharma
Tue, 12/6/22 - 08:54 pm
GSK
Sanofi
Takeda
Singapore
biologics
FDA grants priority review to Takeda’s BLA for dengue vaccine candidate
Pharmaceutical Business Review
Sat, 11/26/22 - 07:18 pm
Takeda
FDA
TAK-003
vaccines
dengue
Takeda touts positive first-line leukemia results — but isn't quite ready to reveal the hard data
Endpoints
Thu, 11/17/22 - 11:36 pm
Takeda
Ariad Pharmaceuticals
Iclusig
clinical trials
acute lymphoblastic leukemia
Seagen's highest selling drug snags a label expansion for pediatric cancer patients
Endpoints
Sun, 11/13/22 - 07:01 pm
Seagen
Takeda
Adcetris
Hodgkin's lymphoma
FDA
pediatric
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »